Osamu Tomita

Significance of CD66c expression in childhood acute lymphoblastic leukemia

Nobutaka Kiyokawa, Kazutoshi Iijima, Osamu Tomita et al. · Leukemia Research · 2013 · 33 citations

Hematological Malignancy, Mixed-phenotype Acute Leukemia, Hematology +5

Effects of insulin-like growth factor-1 on B-cell precursor acute lymphoblastic leukemia

Hiroyuki Yamada, Kazutoshi Iijima, Osamu Tomita et al. · International Journal of Hematology · 2012 · 26 citations

Hematological Malignancy, Lymphoid Neoplasia, Mixed-phenotype Acute Leukemia +9

Poor responses to tyrosine kinase inhibitors in a child with precursor <scp>B</scp>‐cell acute lymphoblastic leukemia with <i><scp>SNX</scp>2‐<scp>ABL</scp>1</i> chimeric transcript

Aki Masuzawa, Chikako Kiyotani, Tomoo Osumi et al. · European Journal Of Haematology · 2013 · 26 citations

Mixed-phenotype Acute Leukemia, Immunology, Kinase Inhibitors +19

Sensitivity of SNX2-ABL1 toward tyrosine kinase inhibitors distinct from that of BCR-ABL1

Osamu Tomita, Kazutoshi Iijima, Takeshi Ishibashi et al. · Leukemia Research · 2013 · 21 citations · Full text

Ph-like ALL-related novel fusion kinase ATF7IP–PDGFRB exhibits high sensitivity to tyrosine kinase inhibitors in murine cells

Takeshi Ishibashi, Akinori Yaguchi, Kazuki Terada et al. · Experimental Hematology · 2015 · 13 citations · Full text

Signal Transduction, Signaling Pathway, High Sensitivity +11